Amin Alizadeh
Research Subjects
Amin Alizadeh has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amirhossein Salmannezhad
Clinical Research Development Unit of Akhtar Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication Atefeh Najafikhah
1 shared publication- Fatemeh Abbasi
Department of Medicine, Islamic Azad University, Tonekabon 4684161167, Iran
1 shared publication - Ghazaleh Talebi
Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication Mehrzad Sadredinamin
1 shared publication- Mojdeh Hakemi-Vala
Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 February 2026
- Published by Taylor & Francis in Research and Reports in Urology
- Vol. ume 18, 1-9
Quinolone Resistance and Virulence Genes Prevalence of Uropathogenic Escherichia coli Isolated from Kidney Transplant Recipients with Urinary Tract Infections in Tehran, Iran
Kidney transplantation is the last suggested treatment option for patients with end-stage kidney disease. Uropathogenic Escherichia coli (UPEC) is a leading cause of urinary tract infections (UTIs) in transplant recipients. The rising resistance rates to therapeutic antibiotics and the presence of various virulence factors in E. coli pose serious concerns for this vulnerable population. This study aimed to investigate quinolone resistance and key virulence genes in UPEC isolates from kidney transplant recipients. Fifty E. coli isolates were collected from kidney transplant recipients diagnosed with UTIs who were referred to Yekta, Gholhak, and Labbafi Nezhad Hospital laboratories in Tehran, Iran, from 2022 to 2024. Antimicrobial susceptibility testing (AST) was performed using the Kirby–Bauer disc diffusion method. Additionally, polymerase chain reaction (PCR) was conducted to detect the presence of ompT, fimH, hlyA, aac (6’)-Ib, qnrA, and qnrB genes. The resistance rates for the following antibiotics were as follows: ampicillin (94%), amoxicillin-clavulanate (54%), ampicillin-sulbactam (64%), piperacillin-tazobactam (54%), cefazolin (88%), cefepime (70%), cefotaxime (80%), cefoxitin (48%), cefpodoxime (80%), doripenem (16%), ertapenem (20%), meropenem (72%), imipenem (18%), gentamicin (34%), tobramycin (44%), amikacin (28%), ciprofloxacin (62%), trimethoprim/sulfamethoxazole (70%), nitrofurantoin (20%), and fosfomycin (86%). Additionally, the frequencies of quinolone-associated resistance genes were reported, with aac (6′)-Ib at 30%, qnrA at 18%, and qnrB at 8%. The distribution of virulence genes includes ompT at 40%, fimH at 82%, and hlyA at 10%. The rising resistance rates to ciprofloxacin, combined with the higher prevalence of a specific virulence gene in E. coli isolates from kidney transplant recipients with UTIs, underscore the need for phenotypic and molecular antimicrobial susceptibility testing. Additionally, analyzing virulence genes is crucial for developing effective treatment strategies and preventing E. coli infections in UTI patients.
- 1 February 2026
- Published by Taylor & Francis in Research and Reports in Urology
- Vol. ume 18, 1-9
Open AccessQuinolone Resistance and Virulence Genes Prevalence of Uropathogenic Escherichia coli Isolated from Kidney Transplant Recipients with Urinary Tract Infections in Tehran, Iran
Kidney transplantation is the last suggested treatment option for patients with end-stage kidney disease. Uropathogenic Escherichia coli (UPEC) is a leading cause of urinary tract infections (UTIs) in transplant recipients. The rising resistance rates to therapeutic antibiotics and the presence of various virulence factors in E. coli pose serious concerns for this vulnerable population. This study aimed to investigate quinolone resistance and key virulence genes in UPEC isolates from kidney transplant recipients. Fifty E. coli isolates were collected from kidney transplant recipients diagnosed with UTIs who were referred to Yekta, Gholhak, and Labbafi Nezhad Hospital laboratories in Tehran, Iran, from 2022 to 2024. Antimicrobial susceptibility testing (AST) was performed using the Kirby–Bauer disc diffusion method. Additionally, polymerase chain reaction (PCR) was conducted to detect the presence of ompT, fimH, hlyA, aac (6’)-Ib, qnrA, and qnrB genes. The resistance rates for the following antibiotics were as follows: ampicillin (94%), amoxicillin-clavulanate (54%), ampicillin-sulbactam (64%), piperacillin-tazobactam (54%), cefazolin (88%), cefepime (70%), cefotaxime (80%), cefoxitin (48%), cefpodoxime (80%), doripenem (16%), ertapenem (20%), meropenem (72%), imipenem (18%), gentamicin (34%), tobramycin (44%), amikacin (28%), ciprofloxacin (62%), trimethoprim/sulfamethoxazole (70%), nitrofurantoin (20%), and fosfomycin (86%). Additionally, the frequencies of quinolone-associated resistance genes were reported, with aac (6′)-Ib at 30%, qnrA at 18%, and qnrB at 8%. The distribution of virulence genes includes ompT at 40%, fimH at 82%, and hlyA at 10%. The rising resistance rates to ciprofloxacin, combined with the higher prevalence of a specific virulence gene in E. coli isolates from kidney transplant recipients with UTIs, underscore the need for phenotypic and molecular antimicrobial susceptibility testing. Additionally, analyzing virulence genes is crucial for developing effective treatment strategies and preventing E. coli infections in UTI patients.
- Open Access
- 29 December 2024
- Published by Elsevier in Journal of Orthopaedic Reports
- Vol. 4 (1)
Investigating hip muscles function in subtrochanteric fracture stabilized with dynamic condyle screw versus proximal femoral nail anti-rotation
- 29 December 2024
- Published by Elsevier in Journal of Orthopaedic Reports
- Vol. 4 (1)
Open AccessInvestigating hip muscles function in subtrochanteric fracture stabilized with dynamic condyle screw versus proximal femoral nail anti-rotation